Diabetic macular edema Trials in Sacramento, United States
Conditions / Diabetic macular edema / Sacramento, United States
Research into Diabetic macular edema spans multiple therapeutic approaches and trial phases.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06850922 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema | ACTIVE_NOT_RECRUITING | — |
| NCT04432831 | A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT01909791 | Treatment for CI-DME in Eyes With Very Good VA Study | COMPLETED | PHASE3 |
| NCT02302079 | A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) | COMPLETED | PHASE2 |
| NCT03622593 | A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema | COMPLETED | PHASE3 |
| NCT02634333 | Anti-VEGF Treatment for Prevention of PDR/DME | COMPLETED | PHASE3 |
| NCT04108156 | A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME | RECRUITING | PHASE3 |
| NCT04527107 | A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema | COMPLETED | PHASE2 |
| NCT03622580 | A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) | COMPLETED | PHASE3 |
| NCT05476926 | A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products | ACTIVE_NOT_RECRUITING | — |